RN7SL681P

Across TCGA pan-cancer cohorts, RN7SL681P RNA differs between tumor and matched normal tissue in 3 of 18 cancer types tested, making tumor–normal expression one of RN7SL681P’s most consistent transcriptional readouts.

The strongest signal is observed in esophageal carcinoma (ESCA), where RN7SL681P RNA is more highly expressed in tumor relative to normal tissue. In most cancer types RN7SL681P is over-expressed in tumor.

ESCA, PRAD, and LIHC are the cancer types where RN7SL681P tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in RN7SL681P RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
ESCA	All	II,III,IV	+0.260	.022	2	view →
PRAD	All	All	+0.031	.047	2	view →
LIHC	All	All	+0.039	.037	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 3 strongest of 3 lineages.

RN7SL681P–ESCA

Open the ESCA breakdown →